Literature DB >> 11427585

Antimicrobial susceptibilities of Helicobacter pylori isolates under microaerophilic atmospheres established by two different methods.

I Kobayashi1, H Muraoka, T Saika, M Nishida, T Fujioka, M Nasu.   

Abstract

The MICs of clarithromycin, amoxicillin, and metronidazole for 150 Helicobacter pylori isolates were determined using the AnaeroPack system and were compared with those determined using a microaerophilic incubator. The MICs of clarithromycin, amoxicillin, and metronidazole determined under both microaerophilic atmospheres were mostly within one twofold dilution for 146 (97.3%), 150 (100%), and 149 (99.3%) of the isolates, respectively.

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11427585      PMCID： PMC88201          DOI： 10.1128/JCM.39.7.2646-2647.2001

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


  10 in total

Review 1.  Current European concepts in the management of Helicobacter pylori infection. The Maastricht Consensus Report. European Helicobacter Pylori Study Group.

Authors: 
Journal:  Gut       Date:  1997-07       Impact factor: 23.059

2.  Effect of an acidic environment on the susceptibility of Helicobacter pylori to trospectomycin and other antimicrobial agents.

Authors:  Y J Debets-Ossenkopp; F Namavar; D M MacLaren
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1995-04       Impact factor: 3.267

3.  Risk of development of in vitro resistance to amoxicillin, clarithromycin, and metronidazole in Helicobacter pylori.

Authors:  M Sörberg; H Hanberger; M Nilsson; A Björkman; L E Nilsson
Journal:  Antimicrob Agents Chemother       Date:  1998-05       Impact factor: 5.191

4.  Unidentified curved bacilli on gastric epithelium in active chronic gastritis.

Authors:  J R Warren; B Marshall
Journal:  Lancet       Date:  1983-06-04       Impact factor: 79.321

Review 5.  NIH Consensus Conference. Helicobacter pylori in peptic ulcer disease. NIH Consensus Development Panel on Helicobacter pylori in Peptic Ulcer Disease.

Authors: 
Journal:  JAMA       Date:  1994-07-06       Impact factor: 56.272

6.  Rare incidence of interspousal transmission of Helicobacter pylori in asymptomatic individuals in Japan.

Authors:  J Suzuki; H Muraoka; I Kobayasi; T Fujita; T Mine
Journal:  J Clin Microbiol       Date:  1999-12       Impact factor: 5.948

Review 7.  Helicobacter pylori and the pathogenesis of gastroduodenal inflammation.

Authors:  M J Blaser
Journal:  J Infect Dis       Date:  1990-04       Impact factor: 5.226

8.  Eradication of Helicobacter pylori using one-week triple therapies combining omeprazole with two antimicrobials: the MACH I Study.

Authors:  T Lind; S Veldhuyzen van Zanten; P Unge; R Spiller; E Bayerdörffer; C O'Morain; K D Bardhan; M Bradette; N Chiba; M Wrangstadh; C Cederberg; J P Idström
Journal:  Helicobacter       Date:  1996-09       Impact factor: 5.753

9.  Effect of pH variation on the susceptibility of Helicobacter pylori to three macrolide antimicrobial agents and temafloxacin.

Authors:  G J Malanoski; G M Eliopoulos; M J Ferraro; R C Moellering
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1993-02       Impact factor: 3.267

10.  Helicobacter pylori infection and the risk of gastric carcinoma.

Authors:  J Parsonnet; G D Friedman; D P Vandersteen; Y Chang; J H Vogelman; N Orentreich; R K Sibley
Journal:  N Engl J Med       Date:  1991-10-17       Impact factor: 91.245
  10 in total
  2 in total

1.  Validation of a fluorescence in situ hybridization method using peptide nucleic acid probes for detection of Helicobacter pylori clarithromycin resistance in gastric biopsy specimens.

Authors:  Laura Cerqueira; Ricardo M Fernandes; Rui M Ferreira; Mónica Oleastro; Fátima Carneiro; Catarina Brandão; Pedro Pimentel-Nunes; Mário Dinis-Ribeiro; Céu Figueiredo; Charles W Keevil; Maria J Vieira; Nuno F Azevedo
Journal:  J Clin Microbiol       Date:  2013-04-17       Impact factor: 5.948

2.  Inference from the analysis of genetic structure of Helicobacter pylori strains isolates from two paediatric patients with recurrent infection.

Authors:  Sandra Mendoza-Elizalde; Ana Caren Cortés-Márquez; Gerardo Zuñiga; René Cerritos; Pedro Valencia-Mayoral; Alejandra Consuelo Sánchez; Hector Olivares-Clavijo; Norma Velázquez-Guadarrama
Journal:  BMC Microbiol       Date:  2019-08-08       Impact factor: 3.605
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.